openPR Logo
Press release

Strong Growth Ahead: Personalized Cancer Treatment Market Size To Grow At Arecord 10.7% Cagr By 2029

06-03-2025 09:31 AM CET | Health & Medicine

Press release from: The Business Research Company

Personalized Cancer Treatment Market

Personalized Cancer Treatment Market

The Personalized Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Personalized Cancer Treatment Market Size Expected to Be by 2034?
The personalized cancer treatment market size will increase from $181.55 billion in 2024 to $201.57 billion in 2025, at a CAGR of 11.0%. This growth is driven by advancements in genomics, increased cancer prevalence, adoption of personalized medicine, awareness of treatment options, and improved cancer diagnostics.

The personalized cancer treatment market size is projected to grow to $303.01 billion in 2029 at a CAGR of 10.7%. Growth is driven by targeted therapies, AI advancements, increased cancer research investments, and the growing demand for precision medicine. Major trends include combination therapies, digital health tools, liquid biopsy adoption, and immunotherapy expansion.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19135

What Are the Emerging Segments Within the Personalized Cancer Treatment Market?
The personalized cancer treatmentmarket covered in this report is segmented -

1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types
4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users

Subsegments:
1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors
2) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy
3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists
4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes
5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS)
6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19135&type=smp

What Long-Term Drivers Are Shaping Personalized Cancer Treatment Market Trends?
The rising prevalence of cancer is expected to accelerate the growth of the personalized cancer treatment market. The increase in cancer cases is attributed to longer life expectancies, lifestyle factors like smoking and obesity, and greater exposure to carcinogens. Personalized cancer treatments offer tailored therapies for various cancer types, stimulating innovation in precision medicine to improve treatment outcomes. The World Health Organization projected a 77% increase in new cancer cases globally by 2050, reaching over 35 million compared to 20 million in 2022.

Who Are the Top Competitors in Key Personalized Cancer Treatment Market Segments?
Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma

What Are the Major Trends Shaping the Personalized Cancer Treatment Market?
Key companies in the personalized cancer treatment market are focusing on AI-powered multimodal immune profile algorithmic tests to predict patient responses to immunotherapy. For example, in July 2024, Tempus AI, a US health tech company, launched an AI-driven immune profile test to predict how patients will respond to immunotherapy, helping doctors personalize cancer treatment.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/personalized-cancer-treatment-global-market-report

Which Regions Are Becoming Hubs for Personalized Cancer Treatment Market Innovation?
North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Personalized Cancer Treatment Market?
2. What is the CAGR expected in the Personalized Cancer Treatment Market?
3. What Are the Key Innovations Transforming the Personalized Cancer Treatment Industry?
4. Which Region Is Leading the Personalized Cancer Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Strong Growth Ahead: Personalized Cancer Treatment Market Size To Grow At Arecord 10.7% Cagr By 2029 here

News-ID: 4048520 • Views:

More Releases from The Business Research Company

Trends in Growth, Segment Analysis, and Competitive Approaches Influencing the Radio Frequency Identification (RFID) Baggage Handling System (BHS) Market
Trends in Growth, Segment Analysis, and Competitive Approaches Influencing the R …
The radio frequency identification (RFID) baggage handling system (BHS) market is set to experience significant growth over the coming years, driven by advancements in airport technology and evolving passenger needs. As airports continue to modernize and automate their operations, the demand for efficient baggage handling solutions is increasing rapidly. This overview explores the market's size, influential players, emerging trends, and key segments shaping its future. Projecting the Radio Frequency Identification Baggage
Leading Industry Participants Reinforce Their Presence in the Process Information (PI)-To-Cloud Data Broker Solutions Market
Leading Industry Participants Reinforce Their Presence in the Process Informatio …
The process information (PI)-to-cloud data broker solutions industry is positioned for significant expansion as digital transformation accelerates across industrial sectors. Increasing demand for real-time data access and seamless integration between operational technology (OT) and information technology (IT) systems is driving rapid innovations and investments. Let's explore the market size projections, key players, emerging trends, and segment insights shaping this evolving landscape. Projected Market Size Growth in the Process Information (PI)-To-Cloud Data
Future Perspective: Key Trends Shaping the Policy Management Telecom Market Up to 2030
Future Perspective: Key Trends Shaping the Policy Management Telecom Market Up t …
The policy management telecom sector is set to experience significant expansion over the coming years, driven by technological advances and growing network demands. This evolving market is playing a crucial role in supporting the complex needs of modern telecom operators, enabling more efficient management and automation of network policies. Below, we explore the current market size projections, leading companies, key trends, and segmentation details that define this dynamic industry. Strong Growth
Competitive Analysis: Key Market Leaders and New Entrants in the Pantyhose and Tights Industry
Competitive Analysis: Key Market Leaders and New Entrants in the Pantyhose and T …
The pantyhose and tights market is set to witness consistent growth as consumer preferences evolve and new trends gain traction. With increasing emphasis on sustainability, comfort, and style, this sector is poised for meaningful expansion through 2030. Let's dive into the market's valuation, key players, emerging trends, and segmentation to understand the trajectory of this dynamic industry. Forecasted Market Value and Growth Rate of the Pantyhose and Tights Market The

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For